Insmed Inc

Company Profile

Insmed Inc had its IPO on 2000-06-01 under the ticker symbol INSM.

The company operates in the Healthcare sector and Biotechnology industry. Insmed Inc has a staff strength of 736 employees.

Stock update

Shares of Insmed Inc opened at $26.44 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $26.32 - $27.59, and closed at $26.93.

This is a +1.62% increase from the previous day's closing price.

A total volume of 1,227,265 shares were traded at the close of the day’s session.

In the last one week, shares of Insmed Inc have increased by +18.95%.

Insmed Inc's Key Ratios

Insmed Inc has a market cap of $3.78 billion, indicating a price to book ratio of 48.1776 and a price to sales ratio of 10.886.

In the last 12-months Insmed Inc’s revenue was $269.47 million with a gross profit of $190.23 million and an EBITDA of $-647673984. The EBITDA ratio measures Insmed Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Insmed Inc’s operating margin was -243.22% while its return on assets stood at -32.87% with a return of equity of -1453.41%.

In Q2, Insmed Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 18.4%.

Insmed Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-5.19 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Insmed Inc’s profitability.

Insmed Inc stock is trading at a EV to sales ratio of 11.6333 and a EV to EBITDA ratio of -6.9833. Its price to sales ratio in the trailing 12-months stood at 10.886.

Insmed Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.44 billion

Total Liabilities

$204.26 million

Operating Cash Flow

$-274156000.00

Capital Expenditure

$4.88 million

Dividend Payout Ratio

0%

Insmed Inc ended 2024 with $1.44 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.44 billion while shareholder equity stood at $-155745000.00.

Insmed Inc ended 2024 with $0 in deferred long-term liabilities, $204.26 million in other current liabilities, 1428000.00 in common stock, $-3101151000.00 in retained earnings and $136.11 million in goodwill. Its cash balance stood at $612.88 million and cash and short-term investments were $917.77 million. The company’s total short-term debt was $6,604,000 while long-term debt stood at $1.14 billion.

Insmed Inc’s total current assets stands at $1.05 billion while long-term investments were $0 and short-term investments were $304.89 million. Its net receivables were $30.95 million compared to accounts payable of $55.70 million and inventory worth $77.35 million.

In 2024, Insmed Inc's operating cash flow was $-274156000.00 while its capital expenditure stood at $4.88 million.

Comparatively, Insmed Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$26.93

52-Week High

$27.59

52-Week Low

$16.04

Analyst Target Price

$39.42

Insmed Inc stock is currently trading at $26.93 per share. It touched a 52-week high of $27.59 and a 52-week low of $27.59. Analysts tracking the stock have a 12-month average target price of $39.42.

Its 50-day moving average was $22.04 and 200-day moving average was $19.91 The short ratio stood at 8.91 indicating a short percent outstanding of 0%.

Around 129.1% of the company’s stock are held by insiders while 10945.1% are held by institutions.